BioNTech Announces Second Quarter 2023 Financial Results and Corporate UpdateGlobeNewsWire • 08/07/23
BioNTech And Moderna: Fallen Angels Of The COVID Era Are Buys Ahead Of EarningsSeeking Alpha • 07/27/23
BioNTech to Report Second Quarter 2023 Financial Results and Operational Update on August 7, 2023GlobeNewsWire • 07/24/23
How Much Upside is Left in BioNTech SE Sponsored ADR (BNTX)? Wall Street Analysts Think 40.69%Zacks Investment Research • 07/20/23
BioNTech and OncoC4 Initiate Pivotal Phase 3 Trial of BNT316/ONC-392 Program in Metastatic NSCLCGlobeNewsWire • 06/29/23
BioNTech: Navigating Post-Pandemic Challenges With Innovative Therapies And Bold StrategiesSeeking Alpha • 06/18/23
BioNTech Surges On This Promising Update In Its Bid To Take On Bristol Myers In Lung Cancer TreatmentInvestors Business Daily • 06/02/23
BioNTech and OncoC4 Present Positive Phase 1/2 Data for Antibody Candidate BNT316/ONC-392 in Hard-to-Treat NSCLC at ASCOGlobeNewsWire • 06/02/23